{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:35:29Z","timestamp":1775709329509,"version":"3.50.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["5193"],"award-info":[{"award-number":["5193"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193709","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T13:26:48Z","timestamp":1520947608000},"page":"e0193709","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3939-0416","authenticated-orcid":true,"given":"Abdel-Rahman N.","family":"Zekri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enas Reda","family":"El-Sisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira Salah El-Din","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auhood","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola Sayed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El Kassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Barakat","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa Ismail","family":"Abd El-Motaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer A.","family":"Bahnassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of HCC: Consider the Population","volume":"47","author":"S Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2893.2011.01576.x","article-title":"HCV burden of infection in Egypt: Results from a nationwide survey","volume":"19","author":"J Guerra","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref3","first-page":"1081","article-title":"Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma","volume":"12","author":"RW Pang","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1634\/stemcells.2007-0176","article-title":"A CD133-expressing murine liver oval cell population with bilineage potential","volume":"25","author":"CB Rountree","year":"2007","journal-title":"Stem Cells"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ijc.22476","article-title":"CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity","volume":"120","author":"S Yin","year":"2007","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/cr.2011.139","article-title":"The critical role of CD133(+)CD44(+\/high) tumor cells in hematogenous metastasis of liver cancers","volume":"22","author":"Y Hou","year":"2012","journal-title":"Cell Res"},{"key":"ref7","first-page":"563","article-title":"CD133: To be or not to be, is this the real question?","volume":"5","author":"E Irollo","year":"2013","journal-title":"Am J Transl Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2009.04.027","article-title":"Cancer stem cells in hepatocellular carcinoma Recent progress and perspective","volume":"286","author":"T Chiba","year":"2009","journal-title":"Cancer Lett"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"18240","DOI":"10.3748\/wjg.v20.i48.18240","article-title":"Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease","volume":"20","author":"AA Bahnassy","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/onc.2011.500","article-title":"MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and Suppresses liver cancer cell growth in vitro and in vivo","volume":"31","author":"XX He","year":"2012","journal-title":"Oncogene"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1038\/onc.2013.478","article-title":"MicroRNA-192 suppresses liver metastasis of colon cancer","volume":"33","author":"L Geng","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.stem.2010.11.010","article-title":"miR-130b promotes CD133(+) liver tumor-initiating cell Growth,and self-renewal via tumor protein 53-induced nuclear protein1","volume":"7","author":"S Ma","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref13","first-page":"410A","article-title":"Serum MicroRNAs as differential markers and a molecular therapeutic target for HCV associated liver disease","volume":"58","author":"AR Zekri","year":"2013","journal-title":"Hepatology"},{"key":"ref14","article-title":"Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection","author":"AR Zekri","year":"2016","journal-title":"Tumor Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.yexcr.2012.09.007","article-title":"Biology and clinical implications of CD133+ liver cancer stem cells","volume":"319","author":"S Ma","year":"2013","journal-title":"Exp Cell Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/aps.2013.134","article-title":"MicroRNAs are involved in the self-renewal and differentiation of cancer stem cells","volume":"34","author":"ZM Wang","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"ref17","article-title":"The Function of miRNA in Hepatic Cancer Stem Cell","volume":"2013","author":"W Qi","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1582-4934.2011.01282.x","article-title":"Functional Analysis of microRNAs in Human Hepatocellular Cancer Stem Cells","volume":"16","author":"F Meng","year":"2012","journal-title":"J Cell Mol Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.22989","article-title":"Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells","volume":"50","author":"J Ji","year":"2009","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4161\/cbt.9.10.11440","article-title":"MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma","volume":"9","author":"L Yang","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/oncotarget.2157","article-title":"MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells","volume":"5","author":"Y Konno","year":"2014","journal-title":"Oncotarget"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11981","DOI":"10.3390\/ijms140611981","article-title":"Role of EZH2 in the Growth of Prostate Cancer Stem Cells Isolated from LNCaP Cells","volume":"14","author":"K Li","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/0008-5472.CAN-11-2182","article-title":"Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression","volume":"72","author":"B Bao","year":"2012","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"405102","DOI":"10.1088\/0957-4484\/24\/40\/405102","article-title":"Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage","volume":"24","author":"T Nagano","year":"2013","journal-title":"Nanotechnology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/rna.18827","article-title":"Liver-specific microRNA-122: Biogenesis and function","volume":"9","author":"C Jopling","year":"2012","journal-title":"RNA Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir","volume":"15","author":"S Thakral","year":"2015","journal-title":"Curr Gene Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"C Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1074\/jbc.M109.016774","article-title":"MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib","volume":"284","author":"S Bai","year":"2009","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.22806","article-title":"MicroRNA-122, a tumor suppressor MicroRNA that regulates intrahepatic metastasis of hepatocellular carcinoma","volume":"49","author":"WC Tsai","year":"2009","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2008.07.154","article-title":"miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines","volume":"375","author":"CJ Lin","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1478-3231.2011.02750.x","article-title":"MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt\/\u03b2-catenin pathway","volume":"32","author":"J Xu","year":"2012","journal-title":"Liver Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","article-title":"Cyclin G1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma","volume":"67","author":"L Gramantieri","year":"2007","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3748\/wjg.v16.i42.5297","article-title":"Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease","volume":"16","author":"H Salama","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1042\/BST0361220","article-title":"Regulation of hepatitis C virus by microRNA-122","volume":"36","author":"CL Jopling","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/JVI.06242-11","article-title":"Establishment of a Novel Permissive Cell Line for the Propagation of Hepatitis C Virus by Expression of MicroRNA miR122","volume":"86","author":"H Kambara","year":"2012","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2011.07.049","article-title":"Alterations in microRNA expression profile in HCV-infected hepatoma cells: Involvement of miR-491 in regulation of HCV replication via the PI3 kinase\/Akt pathway","volume":"412","author":"H Ishida","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref37","article-title":"MicroRNA-192-5p Promote the Proliferation and Metastasis of Hepatocellular Carcinoma Cell by Targeting SEMA3A","author":"L Yan-Chun","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e40169","DOI":"10.1371\/journal.pone.0040169","article-title":"Ectopic expression of miR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF","volume":"7","author":"Q Bi","year":"2012","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3892\/ol.2015.3264","article-title":"miR\u2011125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K\/AKT\/mTOR signaling pathway","volume":"10","author":"H Tang","year":"2015","journal-title":"Oncol Lett"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1073\/pnas.0913574107","article-title":"MicroRNA miR-125a controls hematopoietic stem cell number","volume":"107","author":"S Guo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/stem.627","article-title":"Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells","volume":"29","author":"U Bissels","year":"2011","journal-title":"Stem Cells"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1038\/onc.2008.178","article-title":"MiR-221 controls CDKN1C\/ p57 and CDKN1B\/p27 expression in human hepatocellular carcinoma","volume":"27","author":"F Fornari","year":"2008","journal-title":"Oncogene"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0907904107","article-title":"MiR221 overexpression contributes to liver tumorigenesis","volume":"107","author":"P Pineau","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"31079","DOI":"10.1074\/jbc.M806041200","article-title":"MicroRNA-221\/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer","volume":"283","author":"JJ Zhao","year":"2008","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156652412798376170","article-title":"miR221\/222 in cancer: their role in tumor progression and response to therapy","volume":"12","author":"M Garofalo","year":"2012","journal-title":"Curr Mol Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.18632\/oncotarget.5979","article-title":"MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b","volume":"7","author":"G Roscigno","year":"2016","journal-title":"Oncotarget"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/0008-5472.CAN-07-6754","article-title":"MicroRNAs 221 and 222 bypass quiescence and compromise cell survival","volume":"68","author":"R Medina","year":"2008","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccr.2009.10.014","article-title":"miR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation","volume":"16","author":"M Garofalo","year":"2009","journal-title":"Cancer Cell"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20100297","article-title":"Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies","volume":"120","author":"J Gui","year":"2011","journal-title":"Clin Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.25695","article-title":"Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis","volume":"56","author":"PJ Chen","year":"2012","journal-title":"Hepatology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1440-1746.2012.07271.x","article-title":"Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma","volume":"28","author":"Y Zhang","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref52","first-page":"731781","article-title":"Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival","author":"LP Zhuang","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1158\/0008-5472.CAN-10-0145","article-title":"MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells","volume":"70","author":"F Fornari","year":"2010","journal-title":"Cancer Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gene.2013.02.055","article-title":"Microarray analysis of microRNA expression in liver cancer tissues and normal control","volume":"523","author":"L Lin","year":"2013","journal-title":"Gene"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biocel.2014.05.020","article-title":"Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma","volume":"53","author":"A Wojcicka","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1007\/s13277-015-3092-0","article-title":"Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma","volume":"36","author":"J Yin","year":"2015","journal-title":"Tumour Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1016\/j.febslet.2014.09.047","article-title":"MiR-199a-3p promotes gastric cancer progression by targeting ZHX1","volume":"588","author":"Z Wang","year":"2014","journal-title":"FEBS Lett"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/15476286.2015.1056975","article-title":"Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells\u2014evidence of unique microRNA cargos","volume":"12","author":"TR Lunavat","year":"2015","journal-title":"RNA Biol"},{"key":"ref59","first-page":"1271","article-title":"MicroRNA expression in differentially metastasizing tumors of the head and neck: adenoid cystic versus squamous cell carcinoma","volume":"35","author":"JA Veit","year":"2015","journal-title":"Anticancer Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.18632\/oncotarget.7651","article-title":"MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor","volume":"7","author":"PR Kuninty","year":"2016","journal-title":"Oncotarget"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1182\/blood-2014-11-612507","article-title":"ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation","volume":"125","author":"MF Alemdehy","year":"2015","journal-title":"Blood"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bjc.6605895","article-title":"microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity","volume":"103","author":"J Zhang","year":"2010","journal-title":"Br J Cancer"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2010.08.034","article-title":"An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer","volume":"119","author":"J Li","year":"2010","journal-title":"Gynecol Oncol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11010-011-0872-8","article-title":"Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells","volume":"375","author":"J Li","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1158\/0008-5472.CAN-10-2475","article-title":"Tumor suppressor miR-22 determines p53 dependent cellular fate through post-transcriptional regulation of p21","volume":"71","author":"N Tsuchiya","year":"2011","journal-title":"Cancer Res"},{"issue":"3","key":"ref66","first-page":"747","article-title":"microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb","volume":"40","author":"J Zhang","year":"2012","journal-title":"Int J Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:34:01Z","timestamp":1540211641000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193709"}},"subtitle":[],"editor":[{"given":"Shrikant","family":"Anant","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]}}}